| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.45 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.31 | 1e-19 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-16 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.29 | 2e-06 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.26 | 2e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.26 | 7e-13 |